Stattic
| Clinical data | |
|---|---|
| Drug class | STAT3 inhibitor |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C8H5NO4S |
| Molar mass | 211.19 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Stattic is a drug that acts as an inhibitor of the transcription factor protein STAT3. It has potential applications in the treatment of cancer and autoimmune disorders.[1][2][3]
References
- ^ Ko HJ, Kim YJ (November 2016). "Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer". Archives of Pharmacal Research. 39 (11): 1597–1608. doi:10.1007/s12272-016-0822-9. PMID 27572156.
- ^ Samad MA, Ahmad I, Hasan A, Alhashmi MH, Ayub A, Al-Abbasi FA, et al. (April 2025). "STAT3 Signaling Pathway in Health and Disease". MedComm. 6 (4) e70152. doi:10.1002/mco2.70152. PMC 11955304. PMID 40166646.
- ^ Wu Z, Lian G, He L, Hu P, Guo Y, Su Z (January 2026). "Targeting JAK-STAT signaling for autoimmune diseases: current understanding, clinical advances, and emerging directions". Immunology and Cell Biology imcb.70078. doi:10.1111/imcb.70078. PMID 41517955.